Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

4-Star Stocks Poised to Pop: sanofi-aventis
Motley Fool
Wednesday, August 12, 2009 - 4:18pm
tags:
Sanofi
Mylan Strengthening Generics Portfolio
Yahoo/Zacks.com
Wednesday, August 12, 2009 - 10:06am
tags:
Mylan, generics, Dr Reddy's, Teva Pharmaceuticals
Schering-Plough settles Clarinex patent litigation
Yahoo/AP
Wednesday, August 12, 2009 - 9:57am
tags:
Clarinex, settlements, Schering Plough, Perrigo Company, GeoPharma
Jazz Pharmaceuticals shares rise in premarket trading following 2nd-qtr profit report
Yahoo/AP
Wednesday, August 12, 2009 - 9:56am
tags:
Jazz Pharmaceuticals, earnings
Drug Chief at the FDA Is Accused Of Conflict
WSJ Online
Wednesday, August 12, 2009 - 9:38am
tags:
FDA
AstraZeneca signs development deal with Forest
Marketwatch
Wednesday, August 12, 2009 - 9:36am
tags:
Forest Labs, partnerships
Sanofi Sticks to Guidance After Eloxatin Copies Approved in U.S.
Bloomberg
Wednesday, August 12, 2009 - 9:34am
tags:
Sanofi, Eloxatin, generics
Wyeth: FDA delays ruling on sales of new Prevnar
Yahoo/AP
Wednesday, August 12, 2009 - 8:40am
tags:
Wyeth, FDA, Prevnar, vaccines
Dendreon: From Data To A Deal?
CNBC
Wednesday, August 12, 2009 - 6:23am
tags:
Dendreon, Sanofi, GSK, Bristol-Myers Squibb
Dendreon Hangs Hopes on Provenge Launch
TheStreet.com
Tuesday, August 11, 2009 - 4:13pm
tags:
Provenge, Dendreon, prostate cancer
Avanir Jumps on Study Results
TheStreet.com
Tuesday, August 11, 2009 - 4:10pm
tags:
Avanir, drug trials, Zenvia
FDA questions higher rates of infection seen with highly anticipated Amgen osteoporosis drug
Yahoo/AP
Tuesday, August 11, 2009 - 4:08pm
tags:
FDA, Amgen, denosumab, osteoporosis
Johnson & Johnson a Steady Bet
Seeking Alpha
Tuesday, August 11, 2009 - 4:07pm
tags:
JNJ
Javelin tumbles on mixed clinical data
Marketwatch
Tuesday, August 11, 2009 - 9:40am
tags:
Javelin, drug trials, Ereska
US review of Amgen bone drug to focus on safety
Reuters
Tuesday, August 11, 2009 - 8:49am
tags:
Amgen, FDA, drug safety, denosumab
Nanosphere, Eli Lilly collaborating on genetic tests for use in drug development
Yahoo/AP
Tuesday, August 11, 2009 - 8:48am
tags:
Nanosphere, Eli Lilly, partnerships
Vanda, Oculus, Sequenom: Biotech Notebook
TheStreet.com
Tuesday, August 11, 2009 - 8:46am
tags:
Vanda, Oculus Innovative Sciences, Sequenom
Privacy rules could hinder drug marketing
Fierce Pharma
Tuesday, August 11, 2009 - 7:26am
tags:
prescription data, drug marketing
AVANIR Announces Positive Phase III Study Results for Zenvia
Yahoo
Tuesday, August 11, 2009 - 7:24am
tags:
Avanir, drug trials, Zenvia
Astellas’s Prograf Faces Competition, Damping Sales
Bloomberg
Tuesday, August 11, 2009 - 7:16am
tags:
Astellas, Prograf, generics, Novartis, Sandoz

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.